| Address: | 3530 Toringdon Way #200, Charlotte, NC 28277, USA |
|---|---|
| Postal code: | 28277 |
| Phone: | (704) 341-1516 |
| Website: | https://www.sec.gov/Archives/edgar/data/1333763/000114420414028750/v377872_sc14d9c.htm |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Chelsea Therapeutics Inc, use the form below and your opinion, advice or comment will appear in this space.
Chelsea Therapeutics Inc is a privately held company in Deerfield, IL and is a Single Location business. Categorized under Commercial Medical Research. Our records show it was established in 2004 and incorporated in North Carolina.
Access the business profile for Chelsea Therapeutics Inc in Charlotte, NC. Search up to date business listings at DandB.com. ... (704) 341-1516. Business Info ...
Chelsea Therapeutics Inc is located at the address 3530 Toringdon Way in Charlotte, North Carolina 28277. For more information contact Simon Pedder, President, Ceo, and Director For maps and directions to Chelsea Therapeutics Inc view the map to the right.
Please note that once you make your selection, it will apply to all future visits to NASDAQ.com. If, at any time, you are interested in reverting to our default settings, please select Default ...
Chelsea Therapeutics Inc Address: 3530 Toringdon Way #200, Charlotte, NC 28277, United States Phone: +1 704-341-1516
Chelsea Therapeutics, Inc. Nick Riehle, Chief Financial Officer (704) 341-1516, ext 101 Investors: The Investor Relations Group Kathryn McNeil/John Nesbett (212) 825-3210.
704-341-1516. Executives ... Chelsea Therapeutics International Ltd. (the "Company") has established the Chelsea Therapeutics International Ltd. Executive Severance ...
chelsea therapeutics inc charlotte • chelsea therapeutics inc charlotte photos • ... (704) 341-1516. chtp.client.shareholder.com. See More. Is this your business?
Chelsea Therapeutics, Inc. to Raise $18.2 Million in Registered Direct Offering ... Chief Financial Officer 704-341-1516 x101 Investor/Media Relations Kathryn McNeil ...
Chelsea Therapeutics, Inc.'s Hypotension Drug Fails to Meet Main Trial Goal; Stock Falls 61.97% @ 2:05PM ET - read this article along with other careers information, tips and advice on BioSpace Skip to main content